Evaluation of the Safety and Efficacy of Single Use Powered Endoscopic Staplers and Cartridges in Thoracic Surgery: A Retrospective Clinical Study

Ezisurg Medical Co. Ltd.0 个研究点目标入组 61 人开始时间: 2025年11月20日最近更新: 2026年1月20日

试验速览

阶段: 不适用
状态: 已完成
发起方
入组人数: 61

研究概览研究设计入排标准研究者记录与标识符相似试验

研究概览

简要总结

The goal of this retrospective, single-arm is to evaluate the safety and performance of the easyEndo™ Powered Single Use Powered Endoscopic Staplers and Cartridges in thoracic surgery. The main question it aims to answer is the safety and performance of the staplers

研究设计

研究类型: Interventional
分配方式: Na
干预模型: Single Group
主要目的: Treatment
盲法: None

入排标准

性别: All
接受健康志愿者: 否

入选标准

•Patients who underwent thoracic surgery (including lobectomy, segmentectomy, wedge resection, etc.) using easyEndo™ Powered Single-Use Powered Endoscopic Staplers and Cartridges at our hospital.
•Surgery date was on or after January 1,
•Patients with complete medical records (including demographic data, surgical details, perioperative management, and follow-up information).
•Patients who completed a 1-year postoperative follow-up, with available and valid follow-up data

排除标准

•Patients who used other brands or types of endoscopic staplers instead of easyEndo™ Powered Single-Use Powered Endoscopic Staplers and Cartridges during surgery.
•Surgery date was before January 1,
•Patients with incomplete medical records or missing key information (e.g., unclear surgical procedures, unrecorded stapler use details, lost to follow-up before 1 year).
•Patients with severe underlying diseases that may affect postoperative outcomes or follow-up, such as end-stage heart, liver, or kidney disease, severe coagulation disorders, or uncontrolled malignant tumors (other than the primary disease requiring thoracic surgery).
•Patients with allergies to the materials of easyEndo™ staplers or cartridges, or who experienced adverse reactions related to stapler material allergies intraoperatively or postoperatively.

研究者

发起方

Ezisurg Medical Co. Ltd.

申办方类型

Other

责任方

Sponsor

相似试验

尚未招募

不适用

LUMENS-1 Canada Early Feasibility Study Clinical Investigation PlanBrain Aneurysm

NCT07259018LuSeed Vascular LTD.10

招募中

1 期

An early Phase 1b Study to assess how safe and effective is the treatment with drugs, called Mosunetuzumab or Glofitamab in Combination with drugs called, CC-220 and CC-99282 in Patients with B-Cell Non-Hodgkin Lymphoma.

2023-505185-28-00F. Hoffmann-La Roche AG52

进行中（未招募）

1 期

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB5285 in Healthy Study Participants

NCT07286682UCB Biopharma SRL80

招募中

1 期

A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7806881 in Healthy Participants

NCT07271693Hoffmann-La Roche128

尚未招募

1 期

Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)

NCT07307053Cancer Institute and Hospital, Chinese Academy of Medical Sciences600